当前位置： SCI文献检索 > AMERICAN JOURNAL OF CLINICAL PATHOLOGY期刊下所有文献 > Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients.

Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients.

Abstract：

:The authors quantified creatine kinase MB (CK-MB) isoenzyme activity and mass in the serum of 81 uremic and 20 nonuremic (control) patients who had no clinical or electrocardiographic evidence of acute myocardial infarction. CK-MB was quantified by three methods: electrophoresis, the QuiCK-MB (International Immunoassay Labs), and the Tandem-E CK-MB (Hybritech, Inc.). The authors then followed all uremic patients for subsequent hospitalization for cardiac disease. Median CK-MB was increased in the serum of the uremic patients as compared with the control patients by all methods. Most uremic patients had CK-MB in serum above the median CK-MB of the control group. Seventeen (21%) uremic patients had CK-MB in serum elevated above the reference range by at least one method. All control patients had CK-MB in the serum within the reference range. Twelve of 81 (15%) uremic patients have subsequently developed acute myocardial infarction (six patients; four died) or angina pectoris (six patients; one died). Eleven patients were specifically hospitalized for cardiac symptoms. One patient had acute myocardial infarction three weeks after renal transplant. With the use of the chi-square test and 2 X 2 contingency tables, patients with CK-MB in serum above 5 U/L by electrophoresis (chi 2 = 5.47; P less than 0.05) or at least 2.9 EU/L by the QuiCK-MB (chi 2 = 6.56; P less than 0.01) appeared to be at increased risk of subsequent hospitalization. The authors conclude that a slight increase of CK-MB in serum is found in most uremic patients. However, CK-MB elevated above reference range in the serum of uremic patients without clinical or electrocardiographic evidence of acute myocardial infarction is not common. When found, elevated CK-MB isoenzyme appears to be associated with an increased risk of subsequent cardiac disease. Therefore, quantification of CK-MB in the serum of uremic patients is more reliable than is implied in the literature.

journal_name

Am J Clin Pathol

journal_title

American journal of clinical pathology

authors

Medeiros LJ,Schotte D,Gerson B

doi

10.1093/ajcp/87.1.103

subject

Has Abstract

pub_date

1987-01-01 00:00:00

pages

103-8

issue

eissn

0002-9173

issn

1943-7722

journal_volume

pub_type

杂志文章

在线工具

Reliability and significance of increased creatine kinase MB isoenzyme in the serum of uremic patients.